Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01827046 · ClinicalTrials.gov registry record · Phase 3
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
A Phase 3 study of Intracerebral Hemorrhage, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 499
- Enrollment target
- 20
- Study locations
NCT01827046 is a Phase 3 study of Intracerebral Hemorrhage that has completed, run by Johns Hopkins University. The registered enrollment target is 499 participants, below the 1,159-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (57% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT01827046, a Phase 3 study of Intracerebral Hemorrhage, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 499 participants
- Enrollment target
- 20
- Study locations
Study Summary
A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).
Conditions Studied
Interventions
- DRUG rt-PA
Study Locations (20)
Illinois
- Northwestern University - Chicago
- Rush University - Chicago
- University of Illinois at Chicago - Chicago
- University of Chicago Medical Center - Chicago
- Northshore University Health System, Evanston - Evanston
- Loyola University Chicago - Maywood
California
- Mercy San Juan Medical Center - Carmichael
- Scripps Health - La Jolla
- University of California, Los Angeles - Los Angeles
- University of California, San Diego - San Diego
- Stanford University - Stanford
Arizona
- Banner Good Samaritan Hospital - Phoenix
- Barrow Neurological Institute - Phoenix
Connecticut
- Hartford Hospital - Hartford
- Yale University - New Haven
Alabama
- University of Alabama at Birmingham - Birmingham
Florida
- Mayo Clinic, Jacksonville - Jacksonville
Georgia
- Gwinnett Medical Center - Lawrenceville
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2013-12-30 |
| Est. Completion | 2018-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01827046
The ClinicalTrials.gov registry entry for NCT01827046 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,159-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (57% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which rt-PA is the first listed.
NCT01827046 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Illinois, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT01827046 about?
NCT01827046 is a clinical study titled "Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III". A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).
What is the current status of trial NCT01827046?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 499 participants. The study started on 2013-12-30. Estimated completion is 2018-09.
What conditions does trial NCT01827046 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage.
What interventions are being tested in trial NCT01827046?
The interventions under investigation include: rt-PA (DRUG).
Who is sponsoring clinical trial NCT01827046?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01827046 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RECRUITING · Phase 3
-
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RECRUITING · Phase 3
-
Statins In Intracerbral Hemorrhage
RECRUITING · Phase 3
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
ACTIVE NOT RECRUITING · Phase 3
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.